<?xml version="1.0" encoding="UTF-8"?>
<ref id="B153-ijms-21-09461">
 <label>153.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.X.</given-names>
   </name>
   <name>
    <surname>Lv</surname>
    <given-names>J.Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Shao</surname>
    <given-names>T.T.</given-names>
   </name>
   <name>
    <surname>Huo</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>Q.L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Prioritizing Candidate Disease MiRNAs by Topological Features in the MiRNA Target-Dysregulated Network: Case Study of Prostate Cancer</article-title>
  <source>Mol. Cancer Ther.</source>
  <year>2011</year>
  <volume>10</volume>
  <fpage>1857</fpage>
  <lpage>1866</lpage>
  <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-11-0055</pub-id>
  <pub-id pub-id-type="pmid">21768329</pub-id>
 </element-citation>
</ref>
